Skip to main content
  • Policy
    Get Involved
    Watch Best of BIO
    Advocacy Toolkit
    BIOAction
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Food and Farm Innovation
    Sustainable Fuels
    Biobased Manufacturing
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    BIO Business Solutions
    Join Today
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    The Right Mix Matters

    Providing tools to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions.

  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO Digital 2021

    June 10-11 & 14-17

    New extended dates for the world’s largest biotech partnering event

    Subscribe for Updates
    BIO Partnering @ JPM
    BIO Partnering @ JPM

    January 11-15, 2021
    Fostering the Success of the Industry

    Evt Bif MegaMenu
    BIO Investor Forum Digital

    October 19-20, 2021
    Watch the Best of BIO Sessions

    Evt CEO MegaMenu
    BIO CEO & Investor Digital Conference

    Feb 16-18, 2021
    Accelerate Discovery. Amplify Returns.

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • How Do I
    How Do I?

    Connect with BIO to save money, meet partners and expand your influence by promoting your company and joining our advocacy efforts. Join to get started today!

    Shape Policy
    Save Money
    Meet Partners
    Promote
    Get Started
    Join Today
  • Search
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
680 Results Found

Jeremy Levin
Challenges and Opportunities in the Biotech Industry in 2020
The 22nd annual BIO CEO & Investor Forum kicked off today with a Welcome and Update on BIO's 2020 Initiatives on Behalf of the Industry given by Jeremy Levin, CEO of Ovid Therapeutics Chair of the Board of Directors of BIO. The industry was established in 1970’s during an era of bipartisan…

Patient at Pharmacy
CMS’s Own Data Do NOT Support Claims on Part B Drug Spending
In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note: “The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and $13 annual deductible hike, but argued that the White House is working to bring…

U.S. Capitol Dome
In Speaker Pelosi’s Extreme Drug Pricing Bill, Funding for NIH is MIA
Supporters of Speaker Pelosi’s extreme drug pricing bill (H.R. 3) want us to believe that they can destroy the biopharmaceutical industry and still produce new cures and treatments for patients in need. The crux of this fairy tale is the promise by supporters of H.R. 3 to reinvest “savings” from…

Prescription Doctor
The Pelosi Plan and "Me Too" Drugs
Supporters of Speaker Pelosi’s drug pricing plan (H.R. 3) claim the bill will discourage the development of so-called “me too” drugs. For example, Rep. Donna Shalala was recently quoted as saying:  “I think it actually will reduce me-too drugs … I think [pharmaceutical companies] are going to…

Patient & Health Advocacy Summit
#BIOSummit19 Concludes with Message of Hope Offered by Innovation
Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health Advocacy Summit (#BIOSummit19) came together to proclaim: “I am BIO.” But as Dr. Julie Gerberding, executive vice president and chief patent officer at Merck and Co., who acted as the event…

Patient & Health Advocacy Summit
FDA Discusses Effective Patient Engagement at #BIOSummit19
For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part of the drug development and review process. However, how that engagement happens can determine how successful it is. This was the key question addressed by the “Practices and Principles: Navigating…

BIO Logo
BIO's Leadership Transition | "The fight continues..."
On Tuesday, October 8, BIO formally announced that its President and CEO Jim Greenwood would be stepping down from the world's largest biotechnology organization in January 2021. In a letter to BIO staff, Greenwood reflected on his rise to BIO and the accomplishments the organization has achieved…

Gavel sitting on top of a book that reads PATENT LAW
#TBT: Debunking Some Common Myths on Patent Protections
The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine the U.S. patent system this morning. Ahead of the hearing – and in honor of #ThrowBackThursay – we are resurfacing a piece by BIO’s Tom DiLenge that helps debunk some of the most…

Woman speaking to pharmacist
The Challenges and Risks of Adopting Foreign Price Controls
The Trump Administration is moving forward with a plan to import foreign price controls into Medicare. Under the proposed International Pricing Index (IPI) model, the federal government would move away from a long-standing market-based reimbursement system to one that is tied to prices paid in…

Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access
BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN
BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered on Capitol Hill, the need to sustain biomedical innovation, and ways to ensure patients have access to the medicines they need with out-of-pocket costs they can afford…

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Digital
BIO CEO & Investor Conference
BIO Investor Forum Digital
BIO IMPACT Digital
BIO Online Learning
BIO DOUBLE HELIX SPONSORS
Eli Lilly and Company
Amgen
Bristol Myers Squibb
Genentech Logo
Johnson & Johnson Logo
Merck
MSD
BIO HELIX SPONSORS
Pfizer Inc logo
Sanofi Logo
AbbVie Logo
1201 Maryland Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200
© BIO 2021 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO